Last month, IceCure Medical’s tumor-freezing technology won FDA approval for treating early-stage breast cancer. Now, the Israel-based medtech is touting a new study showing its procedure combined ...
Third Quarter 2025 Financial Results: Total revenue for the quarter ended September 30, 2025 was $134.2 million, up 12% from $119.8 million in the same period of 2024. This growth and operational ...
In the treatment of larger narrowed blood vessels, drug-coated balloon catheters have been shown to deliver lasting and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback